Wei Xu

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Shuai Xia, Meiqin Liu, Chao Wang et al. · Cell Research · 2020 · 1.4K citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

Shuai Xia, Yun Zhu, Meiqin Liu et al. · Cellular and Molecular Immunology · 2020 · 758 citations · Full text

Life Sciences, Biomedical Sciences, Molecular Biology +10

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

Shuai Xia, Lei Yan, Wei Xu et al. · Science Advances · 2019 · 529 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +5

AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells

Shuai Wang, Zongyang Qiu, Yingnan Hou et al. · Cell Research · 2021 · 511 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines

Lang Rao, Shuai Xia, Wei Xu et al. · Proceedings of the National Academy of Sciences · 2020 · 258 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17